This Article Full Text Full Text (PDF) All Versions of this Article: 40/6/2157    most recent STROKEAHA.108.541490v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Wang, Q. Articles by Xiong, L. PubMed PubMed Citation Articles by Wang, Q. Articles by Xiong, L. Related Collections Apoptosis Acute Cerebral Infarction Other Stroke Treatment - Medical

(Stroke. 2009;40:2157.)
© 2009 American Heart Association, Inc.

Original Contributions

Pretreatment With Electroacupuncture Induces Rapid Tolerance to Focal Cerebral Ischemia Through Regulation of Endocannabinoid System

Qiang Wang, MD, PhD; Ye Peng, MD; Shaoyang Chen, MD; Xingchun Gou, MD; Bo Hu, MD; Juan Du, MD; Yan Lu, MD, PhD Lize Xiong, MD, PhD

From the Departments of Anesthesiology (Q.W., S.C., B.H., J.D., Y.L., L.X.) and Orthopedics (Y.P.), Xijing Hospital, Fourth Military Medical University, Xi’an, China; and the Cell Engineering Research Center & Department of Cell Biology (X.G.), State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China.

Correspondence to Lize Xiong, MD, PhD, Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi Province, China. E-mail lize.xiong{at}hotmail.com

Background and Purpose— Our previous study demonstrated that pretreatment with electroacupuncture (EA) induces rapid tolerance to focal cerebral ischemia. The present study was aimed to investigate the involvement of the endocannabinoid system in the early neuroprotection conferred by EA pretreatment in the animal model of focal cerebral ischemia.

Methods— Two hours after the end of EA pretreatment, focal cerebral ischemia was induced by middle cerebral artery occlusion for 120 minutes in male Sprague-Dawley rats or male C57BL/6 mice. The neurobehavioral scores, infarction volumes, and neuronal apoptosis were evaluated at 24 hours or 7 days after reperfusion in the presence or absence of AM251 (a selective cannabinoid receptor type 1 [CB1] receptor antagonist) or CB1 short interfering RNA. The expression of CB1 receptor and the content of endocannabinoids in the brains were also investigated.

Results— EA pretreatment reduced infarct size, improved neurological outcome, and inhibited neuronal apoptosis at 24 hours or 7 days after reperfusion. The beneficial effects were abolished by AM251. CB1 knockdown by CB1 short interfering RNA attenuated EA pretreatment-induced neuroprotection. EA pretreatment upregulated the neuronal expression of CB1 receptor in the rat brains and elevated the brain tissue content of the endocannabinoid 2-arachidonylglycerol and N-arach-idonoylethanolamine-anandamide. Pretreatment with 2-arachidonylglycerol and N-arach-idonoylethanolamine-anandamide also reduced infarct size and improved neurological outcome.

Conclusion— We conclude that pretreatment with EA increases the production of endocannabinoid 2-arachidonylglycerol and N-arach-idonoylethanolamine-anandamide, which elicits protective effects against transient cerebral ischemia through CB1 receptors. These results suggest a novel mechanism of EA pretreatment-induced rapid tolerance to focal cerebral ischemia.

Key Words: cannabinoid • cerebral ischemia • electroacupuncture • pretreatment